文献速递白血病

强化中枢神经系统导向治疗对未接受颅脑照射的儿童急性淋巴细胞白血病幸存者神经认知结局的影响

The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.
PubMed 文献 · J Clin Oncol · 2022-11-02

圣犹达Total Therapy Study 16(Total 16)显示,对中枢神经系统复发风险最高的初诊儿童急性淋巴细胞白血病(ALL)患儿,早期强化三联鞘内治疗(ITT)改善了中枢神经系统疾病控制。本研究在2007至2017年间纳入479例接受Total 16风险导向化疗的合格患者,其中400例(83.5%)在治疗结束时完成方案规定的神经认知测试,评估强化ITT对治疗结束时神经认知结局的影响。

要点

  • 与年龄常模相比,总体组估计智商、注意力、工作记忆、处理速度、精细运动速度和数学评分显著降低。
  • 低危组中,接受与未接受强化ITT的患者神经认知结局无显著差异(所有P值>.10)。
  • 标危至高危组中,接受强化ITT者工作记忆和精细运动速度更差,注意力不集中和执行功能障碍评分升高。

核心结论

  • 标危至高危组接受强化ITT的患者存在中度增加的神经认知问题风险。
  • 研究结果提示ITT暴露存在阈值效应,可为未来临床试验设计及神经认知监测和干预方法提供参考。

研究设计与样本

  • 圣犹达Total Therapy Study 16(Total 16)研究。
  • 2007年至2017年间,479例接受Total 16风险导向化疗的合格患者中,400例(83.5%)在治疗结束时完成方案规定的神经认知测试。
  • 强化ITT定义为:低危ALL患者累计剂量≥21次(n=70/194),标危至高危ALL患者累计剂量≥27次(n=81/206)。

主要发现

  • 与年龄常模预期相比,总体组估计智商(P<.0001)、注意力(P=.0051)、工作记忆(P=.0001)、处理速度(P=.0002)、精细运动速度(P=.0001)和数学(P=.0087)显著降低。
  • 照护者对患者功能的评分显示,注意力(P=.0173)、执行功能(P=.0001)和适应技能(P=.0001)问题风险升高。
  • 低危治疗组中,接受与未接受强化ITT的患者之间无显著差异(所有P值>.10)。
  • 标危至高危ALL患者中,接受强化ITT者工作记忆(P=.0328)和精细运动速度(P=.0403)更差,注意力不集中(P=.0189)和执行功能障碍(P=.0245)评分升高。
  • 标危至高危组中,接受强化ITT的女性工作记忆评分更低;公共保险状态在两个治疗组中均与更差的神经认知结局相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Findings from St Jude Total Therapy Study 16 (Total 16) showed early intensification of triple intrathecal therapy (ITT) improved CNS disease control for children with newly diagnosed acute lymphoblastic leukemia (ALL) at the greatest risk of CNS relapse. We examined the impact of this treatment on end-of-therapy neurocognitive outcomes. METHODS: Between 2007 and 2017, 400 (83.5%) of 479 eligible patients treated with Total 16 risk-directed chemotherapy completed protocol-directed neurocognitive testing at the end of therapy. Intensified ITT was defined as ≥ 21 cumulative doses for patients with low-risk ALL (n = 70/194) and ≥ 27 doses for those with standard-to-high risk ALL (n = 81/206). RESULTS: Compared with age-normative expectations, the overall group had significantly lower estimated intelligence quotient (P < .0001), attention (P = .0051), working memory (P = .0001), processing speed (P = .0002), fine motor speed (P = .0001), and math (P = .0087). Caregiver ratings of patient functioning showed elevated risk for problems in attention (P = .0173), executive function (P = .0001), and adaptive skills (P = .0001). Among the low-risk treatment group, there were no significant differences between patients treated with or without intensified ITT (all P's >.10). Among patients with standard-to-high risk ALL, those treated with intensified ITT had poorer working memory (P = .0328) and fine motor speed (P = .0403), and elevated ratings of inattention (P = .0189) and executive dysfunction (P = .0245). In the standard-to-high risk group, females treated with intensified ITT had lower working memory scores. Public insurance status was associated with worse neurocognitive outcomes in both treatment groups. CONCLUSION: Standard-to-high risk patients treated with intensified ITT are at moderately increased risk for neurocognitive problems. The findings suggest a threshold effect for ITT exposure, which can inform the design of future clinical trials and approaches to neurocognitive monitoring and intervention.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Jacola LM, Conklin HM, Krull KR, et al. The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation. J Clin Oncol. 2022. PMID: 36322880. doi:10.1200/JCO.22.00263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。